DOJ Indicts Ex-Bristol-Myers Exec For Plavix Deal

Law360, New York (April 23, 2008, 12:00 AM EDT) -- Nearly a year after drugmaker Bristol-Myers Squibb Co. agreed to plead guilty to charges stemming from a controversial patent deal over its blood-thinning drug Plavix, the U.S. Department of Justice has indicted the company's former vice president for allegedly making false statements about the agreement to government regulators.

The indictment, handed down Wednesday, charges former executive Andrew Bodnar with lying to the U.S. Federal Trade Commission about an agreement BMS and partner Sanofi-Aventis SA made with generics maker Apotex Corp., allowing Apotex to market a generic...
To view the full article, register now.